Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maze Therapeutics (MAZE) Interest & Investment Income (2024 - 2025)

Maze Therapeutics has reported Interest & Investment Income over the past 2 years, most recently at $3.5 million for Q4 2025.

  • Quarterly Interest & Investment Income rose 130.28% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Dec 2025, up 153.09% year-over-year, with the annual reading at $11.8 million for FY2025, 153.09% up from the prior year.
  • Interest & Investment Income was $3.5 million for Q4 2025 at Maze Therapeutics, up from $2.9 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $3.5 million in Q4 2025 and troughed at $281000.0 in Q1 2024.